Eledon exchanges 4.2M shares for pre-funded warrant with Coastlands

Eledon Pharmaceuticals, Inc.

Exchange of 4,203,764 common shares for pre-funded warrant at $0.001 exercise price.
Warrant has 4.99% beneficial ownership limitation, can be increased to 19.99% per Nasdaq rules.
Issued under Section 3(a)(9) exemption; exchange closed December 30, 2025.
Counterparty: Coastlands Capital Partners LP.

Key facts

Extracted from this filing and checked against the source text.

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

Eledon Pharmaceuticals, Inc. issued pre-funded warrant to purchase up to 4,203,764 shares of Common Stock of warrant to Coastlands Capital Partners LP.

Security: warrant
Shares: pre-funded warrant to purchase up to 4,203,764 shares of Common Stock
Purchaser: Coastlands Capital Partners LP

Exact text from the filing

the Holder agreed to exchange 4,203,764 shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), for a pre-funded warrant to purchase up to 4,203,764 shares of Common Stock (the “Exchange Warrant” and such exchange of Common Stock for the Exchange Warrant is referred to herein as the “Exchange”).

View on SEC.gov

Browse all equity issuances →

Eledon Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-26-000968

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.